<code id='4B1B349B7A'></code><style id='4B1B349B7A'></style>
    • <acronym id='4B1B349B7A'></acronym>
      <center id='4B1B349B7A'><center id='4B1B349B7A'><tfoot id='4B1B349B7A'></tfoot></center><abbr id='4B1B349B7A'><dir id='4B1B349B7A'><tfoot id='4B1B349B7A'></tfoot><noframes id='4B1B349B7A'>

    • <optgroup id='4B1B349B7A'><strike id='4B1B349B7A'><sup id='4B1B349B7A'></sup></strike><code id='4B1B349B7A'></code></optgroup>
        1. <b id='4B1B349B7A'><label id='4B1B349B7A'><select id='4B1B349B7A'><dt id='4B1B349B7A'><span id='4B1B349B7A'></span></dt></select></label></b><u id='4B1B349B7A'></u>
          <i id='4B1B349B7A'><strike id='4B1B349B7A'><tt id='4B1B349B7A'><pre id='4B1B349B7A'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:6956
          The logo of Department of Justice on a podium — coverage from STAT
          BRENDAN SMIALOWSKI/AFP via Getty Images

          Community Health Systems is facing a new federal probe into its hospital billing practices more than four years after the hospital chain settled separate allegations of fraudulent overbilling.

          CHS, a national system of 71 rural and suburban hospitals, said this week it received a civil investigative demand from the Department of Justice on Jan. 11. Federal investigators asked CHS to hand over documents that covered “practices and procedures related to utilization review, inpatient admissions, and inpatient dialysis at our hospitals.”

          advertisement

          The DOJ initiates these investigations into health care companies when it believes there could be a False Claims Act case, but has not initiated or joined any lawsuits yet.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          What the Wegovy shortage looks like for doctors — and for patients
          What the Wegovy shortage looks like for doctors — and for patients

          Afterphysicallydebilitatingcancertreatment,LaurieBrunnerencounteredanothermedicalhurdle:Shehaddevelo

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

          CarstenSnejbjerg/BloombergLONDON—TheinvestmentarmofNovoNordisk’sparentfoundationisbuyingdrugmanufact